Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BHVN
BHVN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BHVN News
Biohaven and Hubbell Options Trading Active
2d ago
NASDAQ.COM
Valuation Analysis of U.S. Small-Cap Healthcare Stocks
Jun 02 2026
seekingalpha
Biohaven Initiates First-in-Human Dosing for BHV-8100, a Novel PKM2 Modulator
Jun 01 2026
PRnewswire
Biohaven Initiates First-in-Human Study for BHV-8100, a Novel PKM2 Modulator
Jun 01 2026
Newsfilter
Biohaven Reports New Clinical Data on Innovative Therapies
May 27 2026
PRnewswire
Biohaven's New Therapies Show Significant Antibody Reduction
May 27 2026
Newsfilter
Biohaven Reports New Data on Opakalim for Epilepsy Treatment
May 26 2026
PRnewswire
Biohaven Reports New Clinical Data on Opakalim for Epilepsy Treatment
May 26 2026
Newsfilter
Biohaven Q1 Earnings Miss Expectations
May 04 2026
seekingalpha
Biohaven Stock Surges 10.14% Following Analyst Buy Rating
Apr 13 2026
Fool
Biohaven Shares Enter Oversold Territory
Mar 24 2026
NASDAQ.COM
Sarissa Capital Management Acquires Stake in Biohaven Ltd.
Mar 23 2026
Fool
Sarissa Capital Management Increases Stake in Biohaven
Mar 23 2026
NASDAQ.COM
DAFNA Capital Management Increases Biohaven Stake
Mar 22 2026
NASDAQ.COM
DAFNA Capital Increases Biohaven Stake by 720,000 Shares
Mar 22 2026
Fool
Biohaven Completes Enrollment in Obesity Treatment Clinical Trial
Mar 19 2026
PRnewswire
Show More News
